JP2005516072A - 生物活性ケラチンタンパク質 - Google Patents

生物活性ケラチンタンパク質 Download PDF

Info

Publication number
JP2005516072A
JP2005516072A JP2003564069A JP2003564069A JP2005516072A JP 2005516072 A JP2005516072 A JP 2005516072A JP 2003564069 A JP2003564069 A JP 2003564069A JP 2003564069 A JP2003564069 A JP 2003564069A JP 2005516072 A JP2005516072 A JP 2005516072A
Authority
JP
Japan
Prior art keywords
composition
peptide
keratin
skin
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003564069A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005516072A5 (enExample
Inventor
ドナルド アール． カウサー，
Original Assignee
ケラプラスト テクノロジーズ， リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ケラプラスト テクノロジーズ， リミテッド filed Critical ケラプラスト テクノロジーズ， リミテッド
Publication of JP2005516072A publication Critical patent/JP2005516072A/ja
Publication of JP2005516072A5 publication Critical patent/JP2005516072A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4741—Keratin; Cytokeratin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1021—Tetrapeptides with the first amino acid being acidic

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Birds (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
JP2003564069A 2002-01-28 2003-01-28 生物活性ケラチンタンパク質 Pending JP2005516072A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35239602P 2002-01-28 2002-01-28
PCT/US2003/002645 WO2003064449A2 (en) 2002-01-28 2003-01-28 Bioactive keratin peptides

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010067081A Division JP2010155859A (ja) 2002-01-28 2010-03-23 生物活性ケラチンタンパク質

Publications (2)

Publication Number Publication Date
JP2005516072A true JP2005516072A (ja) 2005-06-02
JP2005516072A5 JP2005516072A5 (enExample) 2006-02-09

Family

ID=27663089

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2003564069A Pending JP2005516072A (ja) 2002-01-28 2003-01-28 生物活性ケラチンタンパク質
JP2010067081A Pending JP2010155859A (ja) 2002-01-28 2010-03-23 生物活性ケラチンタンパク質

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010067081A Pending JP2010155859A (ja) 2002-01-28 2010-03-23 生物活性ケラチンタンパク質

Country Status (9)

Country Link
US (2) US7501485B2 (enExample)
EP (1) EP1478328B1 (enExample)
JP (2) JP2005516072A (enExample)
AU (1) AU2003210722B9 (enExample)
CA (1) CA2474723A1 (enExample)
DK (1) DK1478328T3 (enExample)
ES (1) ES2426420T3 (enExample)
NZ (1) NZ534919A (enExample)
WO (1) WO2003064449A2 (enExample)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008019244A (ja) * 2006-06-13 2008-01-31 Dainichiseika Color & Chem Mfg Co Ltd 細胞活性剤
JP2009527274A (ja) * 2006-02-17 2009-07-30 ウェイク・フォレスト・ユニヴァーシティ・ヘルス・サイエンシズ ケラチン医用生体材料から形成されるコーティングおよび生体用インプラント
JP2010524943A (ja) * 2007-04-17 2010-07-22 ウェイク・フォレスト・ユニヴァーシティ・ヘルス・サイエンシズ ケラチンバイオマテリアルを含有する創傷治癒組成物
JP2017516869A (ja) * 2014-06-04 2017-06-22 ジム バイオサイエンシズ，インコーポレイテッド 皮膚の質を改善するための組成物及び方法
JP2023507728A (ja) * 2019-12-17 2023-02-27 スパドエリクサー インコーポレイテッド アリール炭化水素受容体の活性を抑制するペプチド及びこれを用いる化粧料組成物

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2474723A1 (en) * 2002-01-28 2003-08-07 Keraplast Technologies, Ltd. Bioactive keratin peptides
US7153822B2 (en) * 2002-01-29 2006-12-26 Wyeth Compositions and methods for modulating connexin hemichannels
US7439012B2 (en) 2004-08-17 2008-10-21 Wake Forest University Health Sciences Ambient stored blood plasma expanders containing keratose
CN100371017C (zh) * 2004-10-29 2008-02-27 肖应庆 生物角蛋白在制药中的应用
JP2006151940A (ja) * 2004-10-29 2006-06-15 Dainichiseika Color & Chem Mfg Co Ltd 細胞活性剤
US8920827B2 (en) * 2005-10-21 2014-12-30 Wake Forest University Health Sciences Keratin bioceramic compositions
US7202701B1 (en) * 2005-12-06 2007-04-10 Micrel, Inc. Input/output circuit for handling unconnected I/O pads
US7892573B2 (en) * 2006-02-10 2011-02-22 Wake Forest University Health Sciences Nerve regeneration employing keratin biomaterials
US8273702B2 (en) * 2006-02-17 2012-09-25 Wake Forest University Health Sciences Wound healing compositions containing keratin biomaterials
EP2502628B1 (en) * 2006-06-23 2016-12-14 Alethia Biotherapeutics Inc. Polynucleotides and polypeptide sequences involved in cancer
NZ549249A (en) * 2006-08-18 2009-10-30 Univ Massey Methods for reducing the incidence of mastitis by administration of keratin
PL227142B1 (pl) * 2006-11-21 2017-11-30 Inst Medycyny Doświadczalnej I Klinicznej Im M Mossakowskiego Polskiej Akademii Nauk Mikrostrukturalny preparat białkowy zawierajacy zwiazki biologicznie czynne
US9068162B2 (en) 2007-08-17 2015-06-30 Wake Forest University Health Sciences Keratin biomaterials for cell culture and methods of use
WO2010060186A1 (en) 2008-11-03 2010-06-03 Alethia Biotherapeutics Inc. Antibodies that specifically block the biological activity of a tumor antigen
US9045600B2 (en) 2009-05-13 2015-06-02 Keraplast Technologies, Ltd. Biopolymer materials
EP2542564B1 (en) 2010-03-05 2018-05-09 Wake Forest University Health Sciences Controlled delivery system
US8545893B2 (en) 2010-03-08 2013-10-01 Wake Forest University Health Sciences Keratin biomaterials for treatment of ischemia
US9505820B2 (en) * 2010-09-01 2016-11-29 Zotos International, Inc. Hair treatment composition with naturally - derived peptide identical to human hair
EP2640408B1 (en) 2010-11-17 2016-05-25 Wake Forest University Health Sciences Keratin compositions for treatment of bone deficiency or injury
PL226806B1 (pl) 2010-12-06 2017-09-29 Inst Medycyny Doświadczalnej I Klinicznej Im Mirosława Mossakowskiego Pan Preparaty peptydowe oraz peptydy odziałaniu przeciwnowotworowym
DK3173427T3 (da) 2011-03-31 2019-08-05 Adc Therapeutics Sa Antistoffer mod nyre-associeret antigen 1 og antigen-bindende fragmenter deraf
WO2012148720A2 (en) 2011-04-27 2012-11-01 The Regents Of The University Of California Anti-microbial peptides and methods of use thereof
WO2013025941A1 (en) 2011-08-17 2013-02-21 Keranetics Llc Low protein percentage gelling compositions
WO2013025940A1 (en) * 2011-08-17 2013-02-21 Keranetics Llc Angiogenesis promoted by alpha-keratose
WO2013025928A2 (en) 2011-08-17 2013-02-21 Keranetics Llc Methods for extracting keratin proteins
CN102952246B (zh) * 2011-08-18 2015-02-25 香港理工大学 角蛋白肽修饰的聚乙二醇水凝胶,其制备方法与应用
HRP20190946T1 (hr) 2012-01-09 2019-07-26 Adc Therapeutics Sa Sredstva za liječenje trostruko negativnog raka dojke
US9827245B2 (en) 2013-03-15 2017-11-28 KeraNetics, LLC Keratin compositions comprising halofuginone
US9226890B1 (en) 2013-12-10 2016-01-05 Englewood Lab, Llc Polysilicone base for scar treatment
CN109415422B (zh) 2015-10-29 2022-08-16 庆北大学校产学协力团 超低分子角蛋白肽的制备方法及其的利用
WO2017074163A1 (ko) * 2015-10-29 2017-05-04 경북대학교 산학협력단 초저분자 케라틴 펩타이드의 제조 방법 및 그의 이용
CN105273051A (zh) * 2015-11-27 2016-01-27 东山博广天兴食品股份有限公司 一种利用双酶协同水解制备章鱼钙螯合蛋白肽的方法
KR102311325B1 (ko) 2020-01-08 2021-10-14 주식회사 에이더블유바이오 극성 저분자 케라틴 펩타이드를 유효성분으로 포함하는 피부 보습 또는 탄력 증진용 화장료 조성물

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5790910A (en) * 1980-11-27 1982-06-05 Toshiba Corp Method for monitoring water content in oil in oil filled electric equipment
JPS59152333A (ja) * 1983-02-08 1984-08-31 パルフューム・クリスチャン・ディオール 細胞増殖の刺激方法
JPH03506024A (ja) * 1988-07-22 1991-12-26 シロス・タッチ・エルティーディー 皮膚病の治療及び創傷の治癒を促進させる組成物及び方法
WO2000076437A1 (en) * 1999-06-11 2000-12-21 Keraplast Technologies, Ltd. Soluble keratin peptide

Family Cites Families (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US626999A (en) * 1899-06-13 Wire-feeding device
US922692A (en) 1907-10-07 1909-05-25 Byron B Goldsmith Thermoplastic keratin composition.
US926999A (en) 1907-11-25 1909-07-06 Carl Neuberg Process of producing digestible substances from keratin.
US922962A (en) * 1908-06-05 1909-05-25 Frederik Christian Schroeder Machine for gluing textile fabrics.
US960914A (en) 1909-09-21 1910-06-07 Arthur Heinemann Pills for the treatment of diabetes mellitus.
US1214299A (en) 1915-06-30 1917-01-30 William M Grosvenor Manufacturing colloids.
IT377232A (enExample) 1938-08-26 1900-01-01
US2434688A (en) 1942-11-03 1948-01-20 Ralph L Evans Regenerated keratin
US2447860A (en) 1944-11-07 1948-08-24 Us Agriculture Method of dispersing keratin proteins and the composition resulting therefrom
US2517572A (en) 1948-11-23 1950-08-08 Chase B Jones Process of utilizing detergents to solubilize keratin materials
US2814851A (en) 1953-12-11 1957-12-03 Rubberset Company Keratin treating process and products thereof
US3033755A (en) 1961-04-14 1962-05-08 Kolmar Laboratories Process for removing the water soluble materials from a keratin structure and cosmetic or pharmaceutical product formed therefrom
US3655416A (en) 1968-12-18 1972-04-11 Lever Brothers Ltd Lipid-protein membrane and process
US3642498A (en) 1969-09-18 1972-02-15 Gen Mills Inc Method of preparing keratin-containing films and coatings
US4178361A (en) 1973-09-10 1979-12-11 Union Corporation Sustained release pharmaceutical composition
JPS54124043A (en) 1978-03-20 1979-09-26 Kuraray Co Ltd Emulsification of liquid cis-1, 4-polyisoprene rubber
JPS5785308A (en) 1980-11-17 1982-05-28 Kao Corp Hair rinse composition
JPS5791910A (en) 1980-11-28 1982-06-08 Kao Corp Preshampoo-type hair treatment composition
JPS57109797A (en) 1980-12-26 1982-07-08 Kao Corp Preparation of low-molecular weight keratinous substance
JPS57130910A (en) 1981-02-05 1982-08-13 Kao Corp Hair treatment agent
JPS57144213A (en) 1981-03-03 1982-09-06 Kao Corp Hair treatment
US4357274A (en) 1981-08-06 1982-11-02 Intermedicat Gmbh Process for the manufacture of sclero protein transplants with increased biological stability
US4570629A (en) 1982-03-17 1986-02-18 University Of Illinois Foundation Hydrophilic biopolymeric copolyelectrolytes, and biodegradable wound dressing comprising same
LU85081A1 (fr) 1983-11-09 1985-07-17 Oreal Medicament et composition medicamenteuse pour le traitement et/ou la prevention des maladies de la peau mettant en jeu un processus inflammatoire
JPS60220068A (ja) 1984-04-16 1985-11-02 テルモ株式会社 生体被覆膜
JPS621731A (ja) 1985-06-28 1987-01-07 Nippon Zeon Co Ltd 成形品の脱臭方法
DK528285D0 (da) * 1985-11-15 1985-11-15 Novo Industri As Peptider samt praeparater indeholdende disse
JPS6347470A (ja) 1986-08-12 1988-02-29 株式会社神戸製鋼所 壁タテ筋の先組工法
JPS63202582A (ja) 1987-02-13 1988-08-22 株式会社日立製作所 スクリユウ駆動式エレベ−タ
US5047249A (en) 1988-07-22 1991-09-10 John Morris Co., Inc. Compositions and methods for treating skin conditions and promoting wound healing
JPH02212410A (ja) 1989-02-14 1990-08-23 Mandamu:Kk アルカリ処理毛髪のコンディショニング組成剤
JPH0311099A (ja) 1989-06-06 1991-01-18 Seiwa Kasei:Kk ケラチン加水分解物、その製造方法および上記ケラチン加水分解物からなる化粧品基剤
IL95393A0 (en) 1989-08-18 1991-06-30 John Morris Co Odor-masked and stabilized compositions for treating keratinous tissue,skin conditions,and promoting wound healing
JP2748174B2 (ja) 1990-01-29 1998-05-06 株式会社成和化成 化粧品基剤
FR2661414B1 (fr) 1990-04-25 1995-03-24 Michel Jean Pierre Produit a base de keratines modifiees, son procede de preparation et les applications notamment en medecine humaine ou veterinaire.
JPH04174659A (ja) 1990-08-06 1992-06-22 Olympus Optical Co Ltd 側枝血管閉塞具
JPH0482561A (ja) 1990-07-26 1992-03-16 Niigata High Supinaa Kk 創傷被覆材
JPH0491138A (ja) 1990-08-06 1992-03-24 Fujimori Kogyo Kk ケラチンフィルムの製造方法
JP3047923B2 (ja) 1990-11-16 2000-06-05 武田薬品工業株式会社 ケラチン有機溶媒液およびその製造法
GB9121815D0 (en) * 1991-10-15 1991-11-27 Delta Biotechnology Ltd Medicine
US6037135A (en) * 1992-08-07 2000-03-14 Epimmune Inc. Methods for making HLA binding peptides and their uses
JP3094182B2 (ja) 1992-04-09 2000-10-03 清 山内 ケラチンｓ−スルフォ塩を壁構成原料として用いるマイクロカプセル及びその製造方法
JP3094181B2 (ja) 1992-04-09 2000-10-03 清 山内 再生天然ケラチンを壁材とするマイクロカプセル及びその製造方法
JP3138838B2 (ja) 1992-04-30 2001-02-26 東レ・ダウコーニング・シリコーン株式会社 混合粉体の製造方法
JP3283302B2 (ja) 1992-09-22 2002-05-20 株式会社成和化成 還元ケラチンの製造方法
JPH06116300A (ja) 1992-10-07 1994-04-26 Seiwa Kasei:Kk ケラチンフラグメントおよびその製造方法
JP3250858B2 (ja) 1993-02-15 2002-01-28 ライオン株式会社 ケラチン繊維処理組成物
JP3223207B2 (ja) 1993-02-26 2001-10-29 本田技研工業株式会社 連結装置
CN1105029A (zh) 1993-05-24 1995-07-12 花王株式会社 制备溶解蛋白质的方法
JP3518691B2 (ja) 1993-05-25 2004-04-12 清 山内 動物クチクル細胞由来の不溶性還元タンパク質、その製造方法および上記動物クチクル細胞由来の不溶性還元タンパク質を原料として作製された高分子成形品
US5527773A (en) * 1993-08-25 1996-06-18 United States Of America Use of synthetic peptides to disrupt the cytoskeleton
US5691179A (en) * 1993-08-26 1997-11-25 Washington University Cell death regulators
US5965536A (en) * 1993-12-15 1999-10-12 Board Of Regents, The University Of Texas System Methods of inhibiting CXC intercrine molecules
JP3446979B2 (ja) 1994-12-06 2003-09-16 株式会社成和化成 水溶性整髪料
US5634945A (en) 1995-03-02 1997-06-03 Pernia; Luis R. Biological filler and use of same
GB9506926D0 (en) 1995-04-04 1995-05-24 Croda Int Plc Cystine-siicone copolymers and their use for treating keratin substrates
US6586570B1 (en) * 1996-01-11 2003-07-01 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
US5712252A (en) 1996-03-08 1998-01-27 The University Of Tennessee Research Corporation Method of augmenting soft tissue in mammals
US6110889A (en) * 1996-06-14 2000-08-29 Board Of Regents, The University Of Texas System Peptide tumor cell growth inhibitors
RU2108079C1 (ru) 1996-08-16 1998-04-10 Василий Александрович Мензул Способ лечения ожоговых ран
RU2106154C1 (ru) 1996-08-16 1998-03-10 Василий Александрович Мензул Перевязочный материал
US6063061A (en) 1996-08-27 2000-05-16 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
JP3891509B2 (ja) 1997-04-18 2007-03-14 清 山内 高等動物体毛由来の還元タンパク質またはその水性媒体分散物およびその製造方法
JPH10337466A (ja) 1997-06-04 1998-12-22 Akuseenu Kk ケラチンマイクロカプセル及びその製造方法並びにケラチンマイクロカプセルを含有する化粧料
JPH11240822A (ja) 1998-02-24 1999-09-07 Shiseido Co Ltd 毛髪処理剤
WO1999054345A1 (en) * 1998-04-21 1999-10-28 Thomas Jefferson University Cd8 antagonists
JP2001087754A (ja) 1999-09-24 2001-04-03 Relief Fund For Oil Pollution Damage In Fishing Ground 汚染土壌の生物的修復用粉状組成物
KR100312178B1 (ko) 1999-10-06 2001-11-03 서경배 신규한 아미노산 실리콘 폴리머들, 그의 제조방법, 아미노산 실리콘 폴리머로 표면개질된 화장료용 분체 및 이를 함유하는 색조화장료 조성물
JP2002138022A (ja) 2000-10-27 2002-05-14 Seiwa Kasei:Kk 毛髪化粧料および毛髪処理法
CN1298733C (zh) 2001-07-17 2007-02-07 凯瑞泰克有限公司 制造可溶性角蛋白衍生物
BR0212389A (pt) 2001-08-31 2004-08-17 Keratec Ltd Produção de materiais biopolìmeros como pelìcula, fibra, espuma ou adesivo a partir de derivados solúveis de queratina s-sulfonada
CA2474723A1 (en) * 2002-01-28 2003-08-07 Keraplast Technologies, Ltd. Bioactive keratin peptides

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5790910A (en) * 1980-11-27 1982-06-05 Toshiba Corp Method for monitoring water content in oil in oil filled electric equipment
JPS59152333A (ja) * 1983-02-08 1984-08-31 パルフューム・クリスチャン・ディオール 細胞増殖の刺激方法
JPH03506024A (ja) * 1988-07-22 1991-12-26 シロス・タッチ・エルティーディー 皮膚病の治療及び創傷の治癒を促進させる組成物及び方法
WO2000076437A1 (en) * 1999-06-11 2000-12-21 Keraplast Technologies, Ltd. Soluble keratin peptide

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JPN6009008120, ＲＯＧＥＲＳ， Ｍ．Ａ．， ｅｔ ａｌ．, "Ｃｈａｒａｃｔｅｒｉｚａｔｉｏｎ ｏｆ ａ １９０−Ｋｉｌｏｂａｓｅ Ｐａｉｒ Ｄｏｍａｉｎ ｏｆ Ｈｕｍａｎ Ｔｙｐｅ Ｉ Ｈａｉｒ Ｋｅｒａｔｉｎ Ｇｅｎｅｓ", ＴＨＥ ＪＯＵＲＮＡＬ ＯＦ ＢＩＯＬＯＧＩＣＡＬ ＣＨＥＭＩＳＴＲＹ, 1998, Ｖｏｌ．２７３， Ｎｏ．４１, ｐ．２６６８３−２６６９１ *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009527274A (ja) * 2006-02-17 2009-07-30 ウェイク・フォレスト・ユニヴァーシティ・ヘルス・サイエンシズ ケラチン医用生体材料から形成されるコーティングおよび生体用インプラント
JP2009527481A (ja) * 2006-02-17 2009-07-30 ウェイク・フォレスト・ユニヴァーシティ・ヘルス・サイエンシズ ケラチン医用生体材料を含有する凝固および治癒用組成物
JP2008019244A (ja) * 2006-06-13 2008-01-31 Dainichiseika Color & Chem Mfg Co Ltd 細胞活性剤
JP2010524943A (ja) * 2007-04-17 2010-07-22 ウェイク・フォレスト・ユニヴァーシティ・ヘルス・サイエンシズ ケラチンバイオマテリアルを含有する創傷治癒組成物
JP2017516869A (ja) * 2014-06-04 2017-06-22 ジム バイオサイエンシズ，インコーポレイテッド 皮膚の質を改善するための組成物及び方法
JP2023507728A (ja) * 2019-12-17 2023-02-27 スパドエリクサー インコーポレイテッド アリール炭化水素受容体の活性を抑制するペプチド及びこれを用いる化粧料組成物
JP7422431B2 (ja) 2019-12-17 2024-01-26 スパドエリクサー インコーポレイテッド アリール炭化水素受容体の活性を抑制するペプチド及びこれを用いる化粧料組成物

Also Published As

Publication number Publication date
AU2003210722B2 (en) 2008-03-06
EP1478328B1 (en) 2013-06-05
EP1478328A2 (en) 2004-11-24
US7501485B2 (en) 2009-03-10
ES2426420T3 (es) 2013-10-23
EP1478328A4 (en) 2009-08-26
WO2003064449A3 (en) 2004-09-23
US20110070276A1 (en) 2011-03-24
WO2003064449A2 (en) 2003-08-07
US20030228353A1 (en) 2003-12-11
NZ534919A (en) 2006-08-31
US8324346B2 (en) 2012-12-04
JP2010155859A (ja) 2010-07-15
CA2474723A1 (en) 2003-08-07
AU2003210722B9 (en) 2008-05-01
DK1478328T3 (da) 2013-07-22
AU2003210722A2 (en) 2003-09-02

Similar Documents

Publication Publication Date Title
US8324346B2 (en) Bioactive keratin peptides
AU2003210722A1 (en) Bioactive keratin peptides
KR100903984B1 (ko) Aimp1 폴리펩티드 또는 이의 단편을 유효성분으로 포함하는 피부 노화 방지, 주름 개선, 피부 유연 증진 및 탄력 증진용 화장료 조성물
US7560430B2 (en) Elastin digest compositions and methods utilizing same
CN101370821B (zh) 新型肽及其用途
CN102027008A (zh) 生长因子-模拟肽及其用途
CA2624900A1 (en) Fibronectin polypeptides and methods of use
CN103834664B (zh) 重组表皮生长因子egf及其制备方法
WO2013148377A1 (en) Methods for modulating hair growth using truncated laminin-511
US20230331814A1 (en) Peptides derived from fibronectin with improved bioactivity and reduced susceptibility to neutrophil elastase degradation
CN114746436B (zh) 改善温度稳定性和蛋白酶抗性的fgf2多肽及其用途
US9066937B2 (en) Lipoxygenase and its use in wound healing
JPH0920677A (ja) 創傷治癒剤
CN115894626A (zh) 一种抗皮肤衰老的五肽衍生肽段rs及其应用
CN115894615A (zh) 一种抗皮肤衰老的五肽衍生肽段ys及其应用
CN121108307A (zh) 具有三螺旋结构的重组i型胶原蛋白及其制备与应用
HK40006015B (en) Peptides derived from fibronectin with improved bioactivity and reduced susceptibility to neutrophil elastase degradation
HK40006015A (en) Peptides derived from fibronectin with improved bioactivity and reduced susceptibility to neutrophil elastase degradation
NZ752999B2 (en) Peptides derived from fibronectin with improved bioactivity and reduced susceptibility to neutrophil elastase degradation
KR20050016333A (ko) 프로트롬빈 활성화 단백질

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20051216

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060105

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090220

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20090519

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20090526

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090622

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20091120

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100323

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20100604

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20101001

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20111028

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20111107

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20111128

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20111201

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20111226

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20120104